• No results found

[PDF] Top 20 Current and emerging treatment strategies for breast cancer-induced bone loss

Has 10000 "Current and emerging treatment strategies for breast cancer-induced bone loss" found on our website. Below are the top 20 most common "Current and emerging treatment strategies for breast cancer-induced bone loss".

Current and emerging treatment strategies for breast cancer-induced bone loss

Current and emerging treatment strategies for breast cancer-induced bone loss

... Clinicians now have medical evidence to guide treatment decisions in the management of bone loss. Among the bispho- sphonates studied, zoledronic acid has the most potent effect on the preservation ... See full document

7

Current and emerging treatment strategies for Duchenne muscular dystrophy

Current and emerging treatment strategies for Duchenne muscular dystrophy

... A 3-year-old boy is referred for evaluation of developmental delay. He was born after an unremarkable pregnancy at term, with no complications. His development was normal during the first year. Although he is generally ... See full document

13

Current and emerging treatment strategies for vertebral compression fractures

Current and emerging treatment strategies for vertebral compression fractures

... of bone structure (including posterior vertebral body wall) and quan- tify height loss when ...with cancer, several fractures of various ages may commonly coexist, hindering identification of ... See full document

11

Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies

Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies

... The TGF-β family consists of at least five highly conserved polypeptides, with TGF-β1, -β2 and -β3 being the principal mammalian forms. TGF-β1 and -β2 are among the most important stimulators of collagen and proteoglycan ... See full document

13

Current and emerging treatment strategies for the treatment of actinic keratosis

Current and emerging treatment strategies for the treatment of actinic keratosis

... of treatment for actinic keratoses is the use of cryosurgery with liquid nitrogen as the ...of treatment where thin lesions are destroyed with a 5–7 second freeze ... See full document

8

Breast cancer metastasis to the bone: mechanisms of bone loss

Breast cancer metastasis to the bone: mechanisms of bone loss

... non-tumor-containing bone? Th ere are many suspected factors, such as microfractures, loss of mechanical loading, hormones, cytokines, calcium levels and infl ...the current discussion, cancer ... See full document

11

Current and emerging strategies for the treatment of acute pericarditis: a systematic review

Current and emerging strategies for the treatment of acute pericarditis: a systematic review

... Abstract: Pericarditis is a common disorder that has multiple causes and presents in various primary-care and secondary-care settings. It is diagnosed in 0.1% of all hospital admissions and in 5% of emergency room visits ... See full document

8

Current management of treatment-induced bone loss in women
with breast cancer treated in the United Kingdom

Current management of treatment-induced bone loss in women with breast cancer treated in the United Kingdom

... in breast cancer have improved survival but consequently increase the relevance of late ...on bone health. However, investigation and management of cancer treatment-induced ... See full document

6

Management of Painful Bone Metastases: The Interaction between Radiation Therapy and Zoledronate

Management of Painful Bone Metastases: The Interaction between Radiation Therapy and Zoledronate

... osteolytic bone metastases in animal tu- mor models, demonstrating that the addition of early bisphosphonate, clodronate in this case and radiation therapy, significantly improved the density and bone mi- ... See full document

6

Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid

Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid

... Maintaining bone health is important for patients with breast cancer (BC), the most commonly diagnosed cancer in American ...Indeed, bone loss is common throughout the BC disease ... See full document

8

Role of bone anabolic agents in the treatment of breast cancer bone metastases

Role of bone anabolic agents in the treatment of breast cancer bone metastases

... uterine cancer side effects and improved disease-free ...of breast cancers are ER + ...of breast cancer from prevention in high-risk populations to neoadjuvant therapy in advanced-stage ... See full document

9

Impact of denosumab on bone mass in cancer patients

Impact of denosumab on bone mass in cancer patients

... Abstract: Cancer therapy-induced bone loss (CTIBL) is a form of secondary osteoporosis associated with systemic chemotherapy and hormonal ablation ...and treatment of CTIBL is an ... See full document

13

Exercise after breast cancer treatment: current perspectives

Exercise after breast cancer treatment: current perspectives

... of cancer recurrence in ...some cancer treatment-related side effects and improve ...for cancer survivors may be necessary, similar to cardiac rehabilitation exercise programs for cardiac ... See full document

10

Colorectal cancer in Chinese patients: current and emerging treatment options

Colorectal cancer in Chinese patients: current and emerging treatment options

... Colorectal cancer is the second most common cancer in Hong Kong and its inci- dence is rising in economically developed Chinese cities, including Hong Kong and ...colorectal cancer syndromes and ... See full document

12

The effectiveness of zoledronic acid and ibandronic acid as therapy for bone metastases in multiple myeloma: A systematic review

The effectiveness of zoledronic acid and ibandronic acid as therapy for bone metastases in multiple myeloma: A systematic review

... the treatment of bone metastases compared with ibandronic ...latest cancer therapy guidelines recommend zoledronic acid for the early stages of MM with the recommended dose of 4 mg IV in 15 minutes ... See full document

8

Emerging strategies for the treatment of advanced small cell lung cancer.

Emerging strategies for the treatment of advanced small cell lung cancer.

... Besides the inherent differences in mouse models and human subjects, another possible reason for the high drug attrition rates in late stage SCLC clinical studies could be due to the fact that it has been challenging to ... See full document

12

RANK-RANKL signalling in cancers

RANK-RANKL signalling in cancers

... 52. Santini, D., Schiavon, G., Vincenzi, B., Gaeta, L., Pantano, F., Russo, A., Ortega, C., Porta, C., Galluzzo, S., Armento, G., La Verde, N., Caroti, C., Treilleux, I., Ruggiero, A., Perrone, G., Addeo, R., Clezardin, ... See full document

50

Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients

Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients

... for treatment of metastatic bone dis- ease (120 mg subcutaneously every 4 ...spine bone mineral density at 12 ...stage breast cancer patients where the primary endpoint is the time to ... See full document

8

Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology

Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology

... and treatment of bone metastasis requires various types of measures, specialists and ...and treatment, a multidisciplinary team approach is ...with bone metastases mainly from 2003 to 2013, ... See full document

11

Refractory hypercalcemia of malignancy related to vitamin D toxicity: Treatment strategies

Refractory hypercalcemia of malignancy related to vitamin D toxicity: Treatment strategies

... scan breast tumor. The patient underwent a fine needle aspirate of the breast lesion that revealed an estrogen receptor positive ...or bone lesions, although lymphadenopathy was ... See full document

5

Show all 10000 documents...